Letter to the Editor: Can semaglutide result in a tangible cardiovascular benefit in recipients of liver transplants?

Subjects

Subjects :

Humans
Cardiovascular Diseases prevention & control
Cardiovascular Diseases etiology
Hypoglycemic Agents therapeutic use
Hypoglycemic Agents adverse effects
Treatment Outcome
Liver Transplantation adverse effects
Glucagon-Like Peptides therapeutic use
Glucagon-Like Peptides adverse effects
Glucagon-Like Peptides administration & dosage

Details

Language :

English

ISSN :

1527-6473

Volume :

30

Issue :

8

Database :

MEDLINE

Journal :

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Publication Type :

Editorial & Opinion

Accession number :

38497771

Full Text :

https://doi.org/10.1097/LVT.0000000000000364